COVID-19 vaccine support items coming to an end From 1 July, the MBS items for vaccine suitability assessments, and associated items, introduced during the pandemic, will cease.
TGA warns of ‘possible but rare’ RSV vaccines risk Product Information for Arexvy and Abrysvo has been updated to reflect a low risk of Guillain-Barre Syndrome following vaccination.
Fresh push to turn around ‘dire’ flu vaccination rate The RACGP has joined calls to boost influenza vaccinations as cases continue to climb, with increases seen across all Australian jurisdictions.
RSV vaccine approved for use in at-risk over-50s The new TGA approval allows access to the Arexvy vaccine for at-risk adults aged 50–59, expanding the previous indication.
GPs remain the frontline in vaccination With the WHO warning global immunisation gains are at risk, an RACGP expert says GPs are best placed to get vaccination rates up.
Using same arm for vaccination boosts antibody response: Study New Australian research suggests that using the same arm for vaccine boosters could trigger a more rapid immune response.
Shingles vaccine linked to dementia risk reduction The new research found those vaccinated had their risk of new dementia diagnoses reduced by 20% over seven years.
New guidance for complex UTIs in kids The guidelines specifically for complicated infections cover diagnosis and management according to determining features.
Is measles making a comeback in Australia? With diagnoses returning to pre-pandemic levels, and one case transmitted in a waiting room, experts are warning the measles outbreak has significant implications for GPs.
Be prepared for flu season 2025 With declining flu vaccination rates sounding alarm bells, the Chief Medical Officer is calling on GPs to help lift the numbers.